Pulse Biosciences, Inc. Payments of Debt Issuance Costs
Pulse Biosciences, Inc. (PLSE) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-03-31
- Pulse Biosciences, Inc. payments of debt issuance costs for the quarter ending 2024-12-31 was $0.00.
- Pulse Biosciences, Inc. payments of debt issuance costs for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. payments of debt issuance costs for the quarter ending 2023-12-31 was $0.00.
- Pulse Biosciences, Inc. payments of debt issuance costs for the quarter ending 2023-09-30 was $1.00K.
- Pulse Biosciences, Inc. payments of debt issuance costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Pulse Biosciences, Inc. payments of debt issuance costs for fiscal 2023 was $6.00K.
- Pulse Biosciences, Inc. payments of debt issuance costs for fiscal 2022 was $0.00.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-19 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.00K derived: sum of 2 quarters · filed 2025-03-31 | $6.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $6.00K 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $5.00K 10-Q · filed 2024-08-19 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |